Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.62 |
| ▸ | FAAH | O00519 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 10/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL769868 | 1.00 | SLC6A5 (0.62) | SLC6A5FAAHMEN1TP53CYP1A2 | |
| SCHEMBL769870 | 1.00 | SLC6A5 (0.62) | SLC6A5FAAHMEN1TP53CYP1A2 | |
| SCHEMBL9800921 | 1.00 | SLC6A5 (0.62) | SLC6A5FAAHMEN1TP53CYP1A2 | |
| SCHEMBL31348788 | 1.00 | SLC6A5 (0.62) | SLC6A5FAAHMEN1TP53CYP1A2 | |
| SCHEMBL25711820 | 1.00 | SLC6A5 (0.62) | SLC6A5FAAHMEN1TP53CYP1A2 | |
| SCHEMBL3096362 | 1.00 | SLC6A5 (0.62) | SLC6A5FAAHMEN1TP53CYP1A2 | |
| SCHEMBL5146257 | 0.95 | KDM4E (0.65) | SOAT1KDM4E | |
| SCHEMBL6332840 | 0.95 | KDM4E (0.65) | SOAT1KDM4E | |
| SCHEMBL29619662 | 0.95 | KDM4E (0.65) | SOAT1KDM4E | |
| SCHEMBL1702127 | 0.91 | EPHX2 (0.60) | SLC6A5EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1780 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188454-A1 | SIGNAL ACTIVATABLE NUCLEIC ACID CONSTRUCTS WITH WOBBLE BASE PAIRINGS | SWITCH THERAPEUTICS INC. | 2025-06-12 | — | — | US | claimed |
| EP-3286338-B1 | AMPLIFICATION WITH PRIMERS OF LIMITED NUCLEOTIDE COMPOSITION | Atila Biosystems Incorporated (US) | 2023-11-01 | — | — | EP | claimed |
| US-20230128143-A1 | METHOD FOR TREATING CANCER | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2023-04-27 | — | — | US | claimed |
| WO-2023283548-A1 | SIGNAL ACTIVATABLE NUCLEIC ACID CONSTRUCTS WITH WOBBLE BASE PAIRINGS | SWITCH THERAPEUTICS INC. (US) | 2023-01-12 | — | — | WO | claimed |
| US-10612019-B2 | Methods and compositions for weed control | MONSANTO TECHNOLOGY LLC (US) | 2020-04-07 | — | — | US | claimed |
| US-10609930-B2 | Methods and compositions for weed control | MONSANTO TECHNOLOGY LLC (US) | 2020-04-07 | — | — | US | claimed |
| US-10568328-B2 | Methods and compositions for weed control | MONSANTO TECHNOLOGY LLC (US) | 2020-02-25 | — | — | US | claimed |
| EP-3604535-A2 | METHODS AND COMPOSITIONS FOR WEED CONTROL | Monsanto Technology LLC (US) | 2020-02-05 | — | — | EP | claimed |
| US-10023863-B2 | Therapeutics with conformationally restricted monomers | MARINA BIOTECH, INC. (US) | 2018-07-17 | — | — | US | claimed |
| US-20180148775-A1 | AMPLIFICATION WITH PRIMERS OF LIMITED NUCLEOTIDE COMPOSITION | ATILA BIOSYSTEMS, INC. | 2018-05-31 | — | — | US | claimed |
| EP-2206707-A1 | AZOLECARBOXAMIDE COMPOUND OR SALT THEREOF | Astellas Pharma Inc. (JP) | 2010-07-14 | — | — | EP | claimed |
| US-20100015708-A1 | RIBONUCLEIC ACIDS WITH NON-STANDARD BASES AND USES THEREOF | MDRNA, INC. (US) | 2010-01-21 | — | — | US | claimed |
| US-20090286766-A1 | AZOLECARBOXAMIDE DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2009-11-19 | — | — | US | claimed |
| CN-101426774-A | Azolecarboxamide derivative | ASTELLAS PHARMA INC (JP) | 2009-05-06 | — | — | CN | claimed |
| EP-2009005-A1 | AZOLECARBOXAMIDE DERIVATIVE | Astellas Pharma Inc. (JP) | 2008-12-31 | — | — | EP | claimed |
| US-20040033967-A1 | Alkylated hexitol nucleoside analogues and oligomers thereof | K.U.LEUVEN RESEARCH AND DEVELOPMENT (BE) | 2004-02-19 | — | — | US | claimed |
| WO-2002018406-A1 | ALKYLATED HEXITOL NUCLEOSIDE ANALOGUES AND OLIGOMERS THEREOF | K.U.LEUVEN RESEARCH AND DEVELOPMENT (BE) | 2002-03-07 | — | — | WO | claimed |
| EP-0088380-B1 | NOVEL DERIVATIVES OF N,N-SUBSTITUTED AZOLECARBOXAMIDE AND AGRICULTURAL AND HORTICULTURAL FUNGICIDAL OR NEMATICIDAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENTS | Nippon Kayaku Kabushiki Kaisha (JP) | 1986-11-12 | — | — | EP | claimed |
| US-4500536-A | Derivatives of N,N'-substituted azolecarboxamide and agricultural and horticultural fungicidal or nematicidal composition containing same as active ingredients | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1985-02-19 | — | — | US | claimed |
| EP-0088380-A2 | Novel derivatives of N,N-substituted azolecarboxamide and agricultural and horticultural fungicidal or nematicidal composition containing same as active ingredients | Nippon Kayaku Kabushiki Kaisha (JP) | 1983-09-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10609930-B2 | Methods and compositions for weed control | AS3MT, NOTUM, POLR1C | SLC6A5 202/4885FAAH 2041/4885MEN1 4840/4885 |
| US-10612019-B2 | Methods and compositions for weed control | NOTUM, LOXL3, CXXC5 | SLC6A5 989/4885FAAH 3305/4885MEN1 4827/4885 |
| US-20040033967-A1 | Alkylated hexitol nucleoside analogues and oligomers thereof | DERA, HEXA, HEXB | SLC6A5 3836/4885FAAH 2501/4885MEN1 3756/4885 |
| US-20100015708-A1 | RIBONUCLEIC ACIDS WITH NON-STANDARD BASES AND USES THEREOF | NSUN2, NSUN3, RNMT | SLC6A5 2454/4885FAAH 4481/4885MEN1 2426/4885 |
| US-10568328-B2 | Methods and compositions for weed control | CYC1, PRDX5, CYCS | SLC6A5 843/4885FAAH 2829/4885MEN1 4814/4885 |
| US-20090286766-A1 | AZOLECARBOXAMIDE DERIVATIVE | GPR17, NTRK1, TRPV1 | SLC6A5 3264/4885FAAH 1551/4885MEN1 4778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.